Protagonist CEO Sells $5.52 Million in Stock Amid Commercialization Milestone
Protagonist Therapeutics President and CEO Dinesh V. Patel sold 54,700 shares at $101 each on March 24 and 25, 2026, for a total of $5,524,700. Filings show he also exercised options for 54,700 shares at $8.58 per share on the same dates and gifted 50,000 shares on March 23, 2026. The transactions coincide with Protagonist's recent FDA approval of …